TSX:OGIPharmaceuticals
Organigram Global (TSX:OGI) Valuation Check After Swing To Quarterly Net Profit
Organigram Global (TSX:OGI) is back in focus after reporting first quarter 2026 results that shifted from a net loss to net income, with higher sales and revenue, as well as positive earnings per share.
See our latest analysis for Organigram Global.
Despite the swing back to net income, Organigram Global’s share price has had a tough run, with a 30 day share price return of a 26.6% decline and a 1 year total shareholder return of a 9.4% decline. This may suggest that recent enthusiasm around...